Get the Daily Brief
Latest Biotech News
University of Ottawa Launches OMARI: Medical AI Hub Established
The University of Ottawa inaugurated the Ottawa Medical Artificial Intelligence Research Institute (OMARI) to centralize medical-AI research, led by Dr. Khaled El Emam, Canada Research Chair in...
Machine Learning Tool Maps Scope of Paper-Mill Fraud in Cancer Science
Researchers at Queensland developed a machine‑learning tool that identifies suspicious publications and mapped a broad spread of likely paper‑mill outputs affecting cancer research literature. The...
C‑Suite Shakeup and Data Release Send Cardiff Stock Down 45%
Cardiff Oncology reported positive Phase II signals for onvansertib in RAS‑mutated metastatic colorectal cancer while simultaneously announcing the resignations of CEO Mark Erlander and CFO James...
In vivo CARs: New Reagent Suites Target Translation Bottlenecks
An industry-focused review outlined practical steps to advance in vivo CAR approaches from concept to clinical translation and highlighted commercial reagent solutions aimed at de‑risking the...
FDA halts Regenxbio trials: cancer case triggers clinical holds
The FDA placed clinical holds on two Regenxbio gene‑therapy studies after a participant developed cancer, raising fresh safety questions for adeno‑associated virus (AAV) and related viral vector...
Thermo Fisher shutters Franklin lab — more than 100 layoffs
Thermo Fisher Scientific announced the closure of its Franklin, Massachusetts facility and notified state regulators of workforce reductions affecting over 100 employees. The company filed a...
Cardiff leadership exit: shares plunge after Phase II update
Cardiff Oncology disclosed positive Phase II data for onvansertib in RAS‑mutated metastatic colorectal cancer at the same time its CEO and CFO resigned, prompting a sharp market reaction and a...
Nasal H5N1 vaccine prevents infection in rodents: WashU reports
Washington University School of Medicine reported an intranasal adenoviral‑vectored H5N1 vaccine that protected hamsters and mice from highly pathogenic avian influenza strains and remained...
IU chemists discover chemical approach to combat antibiotic resistance
Researchers at Indiana University reported a chemical strategy that restores antibiotic activity against resistant bacteria, presenting a potential adjunct to existing antibiotics. The study...
Brown study reveals pathway to boost glioblastoma therapy response
Scientists at Brown University identified a molecular mechanism that modulates glioblastoma treatment sensitivity and proposed strategies to enhance therapeutic efficacy in preclinical models. The...
Lentiviral vectors retool gene therapy delivery — new techniques reported
A recent study reviewed advances in lentiviral vectors that expand utility for viral gene‑therapy applications, highlighting improvements in tropism, safety, and manufacturing. The research...
Scientists program microbes to synthesize compounds with light
Researchers at the Carl R. Woese Institute for Genomic Biology demonstrated enzymatic transformations inside living microbes that are driven by light, enabling new biosynthetic routes to valuable...
AI system diagnoses sarcopenia accurately — new decision support tool
Developers unveiled the Sarcopenia Artificial Intelligence Diagnostic Decision Support System (SAID DSS), an AI model that identifies sarcopenia with high accuracy using clinical and imaging...
Machine learning exposes scope of paper‑mill fraud in cancer research
A Queensland research team developed a machine‑learning tool that mapped the prevalence and networks of fraudulent papers—so‑called paper mills—affecting the cancer literature. The model...
AstraZeneca doubles down on obesity — $1.2B up front in CSPC China pact
AstraZeneca signed a landmark partnership with China’s CSPC that delivers $1.2 billion up front and grants the U.K. pharma access to eight obesity assets, including a once‑monthly GLP‑1/GIP...
Intranasal H5N1 vaccine prevents infection in rodents: WashU study
Researchers at Washington University in St. Louis reported an intranasal adenoviral‑vectored H5N1 vaccine that produced robust mucosal and systemic immunity and prevented H5N1 infection in mice...
FDA halts two Regenxbio gene‑therapy trials — cancer case raises approval doubts
Regulatory scrutiny intensified after the FDA placed tests of two Regenxbio gene‑therapy programs on clinical hold following a patient’s cancer diagnosis in one study, according to MedCity News....
Cardiff’s CEO exit rattles investors — shares plunge despite Phase II news
Cardiff Oncology reported positive Phase II data for onvansertib in RAS‑mutated metastatic colorectal cancer but the company simultaneously announced the resignations of CEO Mark Erlander and CFO...
CZI lays off 70 staff — overhauls for AI‑powered biology push
The Chan Zuckerberg Initiative announced cuts of about 70 employees as it reorients toward AI‑driven biomedical research and consolidates prior research entities into a unified science...
Thermo Fisher to close Massachusetts site — 100+ layoffs at Franklin facility
Thermo Fisher Scientific filed notice of a facility closure at 27 Forge Parkway in Franklin, Massachusetts, and plans layoffs affecting more than 100 employees, according to reporting on the...